Numasawa Yohei, Inohara Taku, Ishii Hideki, Kuno Toshiki, Kodaira Masaki, Kohsaka Shun, Fujii Kenshi, Uemura Shiro, Amano Tetsuya, Kadota Kazushige, Nakamura Masato
Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Am J Cardiol. 2017 Mar 15;119(6):826-831. doi: 10.1016/j.amjcard.2016.11.034. Epub 2016 Dec 18.
Previous studies have reported that women have worse outcomes than men after percutaneous coronary intervention (PCI), especially in patients with ST-elevation myocardial infarction. However, gender-related differences in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) have not been thoroughly investigated. In the Japanese nationwide registry, a total of 43,239 patients with NSTE-ACS from 861 hospitals underwent PCI in 2014. Overall, 11,326 patients (26.2%) were women. The women were older (75.0 ± 10.3 vs 68.7 ± 11.4 years, p <0.001) and had a higher prevalence of hypertension (p <0.001), hyperlipidemia (p = 0.003), and heart failure (p <0.001) compared with men. For inpatient outcomes, women had a higher rate of overall complications (3.3% vs 2.4%, p <0.001) and bleeding complications that required blood transfusion (0.6% vs 0.2%, p <0.001). On multivariate analysis, female gender was an independent predictor of overall (odds ratio [OR] 1.20, 95% CI 1.04 to 1.38; p = 0.011) and bleeding complications (OR 1.94, 95% CI 1.35 to 2.79; p <0.001) after adjustment but was not associated with in-hospital mortality (OR 1.05, 95% CI 0.79 to 1.40; p = 0.747). In conclusion, in patients with NSTE-ACS who underwent PCI, women were at greater risk than men for in-hospital complications, especially in bleeding complications.
以往研究报告称,经皮冠状动脉介入治疗(PCI)后女性的预后比男性差,尤其是在ST段抬高型心肌梗死患者中。然而,非ST段抬高型急性冠状动脉综合征(NSTE-ACS)患者中与性别相关的差异尚未得到充分研究。在日本全国性登记研究中,2014年共有来自861家医院的43239例NSTE-ACS患者接受了PCI治疗。总体而言,11326例患者(26.2%)为女性。与男性相比,女性年龄更大(75.0±10.3岁对68.7±11.4岁,p<0.001),高血压(p<0.001)、高脂血症(p=0.003)和心力衰竭(p<0.001)的患病率更高。对于住院结局,女性总体并发症发生率更高(3.3%对2.4%,p<0.001)以及需要输血的出血并发症发生率更高(0.6%对0.2%,p<0.001)。多因素分析显示,女性性别是调整后总体并发症(比值比[OR]1.20,95%可信区间1.04至1.38;p=0.011)和出血并发症(OR 1.94,95%可信区间1.35至2.79;p<0.001)的独立预测因素,但与住院死亡率无关(OR 1.05,95%可信区间0.79至1.40;p=0.747)。总之,在接受PCI治疗的NSTE-ACS患者中,女性发生院内并发症的风险高于男性,尤其是出血并发症。